CMND Stock — Clearmind Medicine Inc. Common Shares

Clearmind Medicine Inc. Common Shares (CMND)

Updated October 16, 2026.

CMND is a Stock. Its deepest 1-year drawdown was 99.8%.

Clearmind Medicine Inc. is a clinical-stage pharmaceutical company developing novel psychedelic medicines to treat alcohol use disorder, eating disorders, obesity, depression, anxiety, and post-traumatic stress disorder, with lead programs including the MEAI compound and CM-CMND-001 in Phase I/IIa clinical trials. The company does not currently distribute to shareholders. This security appeals to investors with a high risk tolerance interested in early-stage pharmaceutical development and the emerging psychedelic medicine sector.

CMND performance

Returns are updating. CMND's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 99.8%.

CMND key facts

Asset type

Stock

Asset class

Equity

Inception date

08/16/2021

Distribution frequency

None

Last close

$6.26 (as of 2026-10-16)

Market cap

$3,176,400

Average volume

3874.0

Beta

0.456

Payout ratio

0.0%

EPS

$-461.20

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

CMND risks and drawbacks

The deepest 1-year drawdown on record here is 99.8%.

Who may consider CMND — and who may not

It is a weaker fit for investors who need monthly cash flow (CMND does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on CMND

• All tickers starting with C

Tagged: Healthcare.

Frequently asked questions